-
Tips for becoming a good boxer - November 6, 2020
-
7 expert tips for making your hens night a memorable one - November 6, 2020
-
5 reasons to host your Christmas party on a cruise boat - November 6, 2020
-
What to do when you’re charged with a crime - November 6, 2020
-
Should you get one or multiple dogs? Here’s all you need to know - November 3, 2020
-
A Guide: How to Build Your Very Own Magic Mirror - February 14, 2019
-
Our Top Inspirational Baseball Stars - November 24, 2018
-
Five Tech Tools That Will Help You Turn Your Blog into a Business - November 24, 2018
-
How to Indulge on Vacation without Expanding Your Waist - November 9, 2018
-
5 Strategies for Businesses to Appeal to Today’s Increasingly Mobile-Crazed Customers - November 9, 2018
Martin Shkreli ousted from second pharmaceuticals company days after his arrest
Above: Martin Shkreli is escorted by law enforcement agents in NY after being taken into custody last week following a securities probe.
Advertisement
KaloBios Pharmaceuticals, a California biotechnology company that Shkreli gained control of in November, announced Monday that he had been terminated as chief executive and had resigned from his seat on the board Thursday, the day he was arrested. Mr. Shkreli, who was accused Thursday of securities fraud in connection with his operation of a hedge fund, attended but did not graduate from Hunter College High School.
He was charged with securities fraud and conspiracy for setting up a Ponzi-like scheme at his former hedge fund MSMB Capital Management and Retrophin Inc.
He pleaded not guilty and was released on $5 million bail.
On Monday, he and his attorneys finally regained control of the recently arrested ex-pharmaceutical C.E.O.’s Twitter account, after it was hacked and began sending, without context, messages all-too similar to things Shkreli might actually tweet. The drug to be tested was KB003, which was being developed to treat a form of leukemia. He faces 20 years in prison if convicted. On the day of his arrest, the stock dropped 50% before being halted.
The former hedge fund manager who raised the price of an AIDS drug by 5500% has said the price hike is the reason the Federal Bureau of Investigation looked to arrest him.
He became the subject of widespread scorn in September for defiantly raising the price of Daraprim from $13.50 to $750 a pill, an increase he defended as “a good business decision”.
Martin Shkreli, whose arrest delighted countless people appalled by his unapologetic stance after hiking the price of a life-saving drug by 5,000 percent, is being replaced on an interim basis by Ron Tilles, according to a statement issued Friday by Turing, which is privately held.
Shkreli has often used Twitter to parry with critics, project what some call a “pharma-bro” persona-which includes a love of hip-hop that led him to buy an unreleased Wu-Tang Clan album for $2 million-and even make industry connections.
Advertisement
In other news, it was reported on Sunday that his Twitter account has been hacked. He was later ousted from the company, where he’d been CEO, and sued by its board. The company announced it would shut down right before Shkreli and a group of investors swooped in with cash and pledges of financing to keep it going.